No abstract available
MeSH terms
-
Abnormalities, Drug-Induced / prevention & control*
-
Adverse Drug Reaction Reporting Systems / organization & administration*
-
Dermatologic Agents / adverse effects*
-
Dermatologic Agents / therapeutic use
-
Female
-
Humans
-
Isotretinoin / adverse effects*
-
Isotretinoin / therapeutic use
-
Pregnancy
-
Pregnancy Complications / chemically induced
-
Pregnancy Complications / prevention & control*
-
Program Development
-
Program Evaluation
-
United States
-
United States Food and Drug Administration
Substances
-
Dermatologic Agents
-
Isotretinoin